Evaluation of surgical intervention for chronic suppurative otitis media in patients with hematologic diseases.
Saved in:
| Title: | Evaluation of surgical intervention for chronic suppurative otitis media in patients with hematologic diseases. |
|---|---|
| Authors: | Wang, Ai (AUTHOR), Li, Qingfeng (AUTHOR), Zheng, Hongwei (AUTHOR), Han, Lin (AUTHOR), Xue, Jinmei (AUTHOR), Yu, Lisheng (AUTHOR) |
| Source: | Acta Oto-Laryngologica. May2025, Vol. 145 Issue 5, p390-394. 5p. |
| Subjects: | Otitis media, Patient safety, Research funding, Treatment effectiveness, Retrospective studies, Chronic diseases, Blood diseases, Length of stay in hospitals, Disease relapse, Symptoms |
| Abstract (English): | Objective: To evaluate the effectiveness and safety of surgical treatment for chronic suppurative otitis media (CSOM) in patients with hematologic diseases. Methods: This retrospective study included 26 patients (16 males and 10 females; median age of 36.5 years) with CSOM and hematological diseases treated over three years. All patients received chemotherapy before surgery. Preoperative symptoms included hearing loss accompanied by intermittent ear discharge, ear pain, and dizziness, but no facial paralysis. Surgical indications were recurrent infections, invasive fungal otitis during chemotherapy, or planned hematopoietic stem cell transplantation. Based on the extent of the lesions and intraoperative conditions. Results: All surgeries were successful with a median duration of 70.5 (36–120) minutes and intraoperative blood loss of < 20 mL, without postoperative complications. Hospital stay averaged 9 (8–15) days. During the 6–24-month follow-up, one patient experienced a recurrence of CSOM, and one died from worsening hematologic disease. The remaining patients recovered well and continued to receive appropriate hematologic treatment. Conclusions: Surgical treatment is a safe and effective option for patients with CSOM and hematologic diseases. It can improve patient outcomes and facilitate ongoing and subsequent hematologic cure. [ABSTRACT FROM AUTHOR] |
| Abstract (Chinese): | 背景：随着治疗技术的提高和生存率的提高, 血液病患者慢性化脓性中耳炎（CSOM）的发病率不断上升。CSOM的治疗为血液病的后续治疗提供了良好的条件。 目的：评价血液病患者慢性化脓性中耳炎（CSOM）手术治疗的有效性和安全性。 方法：本回顾性研究纳入了26例（16例男性, 10例女性；中位年龄36.5岁）CSOM和血液病患者。他们的治疗时间超过3年。所有患者在手术前均接受化疗。术前症状包括听力下降, 伴有间歇性耳部流脓、耳痛和头晕, 但无面瘫。手术指征为复发性感染、化疗期间侵袭性真菌性中耳炎或计划进行造血干细胞移植。根据病变范围和术中情况, 16例患者接受I型鼓室成形术, 10例患者接受乳突切除加鼓室成形术。 结果：所有手术均成功。中位手术时间为70.5（36–120）分钟, 术中出血量<20mL, 无术后并发症。平均住院时长为9（8–15）天。在6–24个月的随访中, 1例患者CSOM复发, 1例因血液病恶化死亡。其余患者恢复良好, 并继续接受适当的血液病治疗。 结论：手术治疗是CSOM和血液病患者安全有效的选择。它可以改善患者的结果, 并促进正在进行的和后续的血液病治愈。 [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Oto-Laryngologica is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Objective: To evaluate the effectiveness and safety of surgical treatment for chronic suppurative otitis media (CSOM) in patients with hematologic diseases. Methods: This retrospective study included 26 patients (16 males and 10 females; median age of 36.5 years) with CSOM and hematological diseases treated over three years. All patients received chemotherapy before surgery. Preoperative symptoms included hearing loss accompanied by intermittent ear discharge, ear pain, and dizziness, but no facial paralysis. Surgical indications were recurrent infections, invasive fungal otitis during chemotherapy, or planned hematopoietic stem cell transplantation. Based on the extent of the lesions and intraoperative conditions. Results: All surgeries were successful with a median duration of 70.5 (36–120) minutes and intraoperative blood loss of < 20 mL, without postoperative complications. Hospital stay averaged 9 (8–15) days. During the 6–24-month follow-up, one patient experienced a recurrence of CSOM, and one died from worsening hematologic disease. The remaining patients recovered well and continued to receive appropriate hematologic treatment. Conclusions: Surgical treatment is a safe and effective option for patients with CSOM and hematologic diseases. It can improve patient outcomes and facilitate ongoing and subsequent hematologic cure. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00016489 |
| DOI: | 10.1080/00016489.2025.2471940 |
